News

CiiTA is moving!

Having outgrown our second location in five years – we are moving to a third! Effective July 6th, CiiTA will be located at 815 SW Second Avenue, Suite 300; Portland, Oregon 97204.  Feel free to come by for a visit!

Read More

New Members of the CiiTA Team

As CiiTA continues to grow and evolve, we occasionally get to announce the onboarding of a new teammate. Please join me in welcoming Jason Osieczanek and Pujitha Palem to the CiiTA team. Jason is taking over the role of Office Manager and has already demonstrated his competence and skills in running the back-office functions of…

Read More

Jason Hardaway speaking at the CBI 340B Manufacturer Summit

CiiTA’s Managing Director Jason Hardaway has once again been invited to speak at the 4th Annual 340B Manufacturer Summit being held in Washington DC this August. His topic, “Best Practices for Communicating with States and Covered Entities to Prevent Revenue Leakage,” will be co-presented with Cathy Burton-Meza and Alexis Arroyo. CBI’s 4th Annual 340B Manufacturer…

Read More

HRSA’s Civil Monetary Penalties Rule: Finalized, but Postponed

Clients have been asking for our take on the Health Resources and Services Administration (“HRSA”) 340B Drug Pricing Program Ceiling Price and Civil Monetary Penalties Rule (the CMP Rule) from May 22, 2017, until October 1, 2017. This Rule, if and when it becomes effective, imposes monetary penalties on manufacturers of up to $5,000 for…

Read More

CiiTA Team Win

One of the things that makes working at CiiTA enjoyable is the variety of skills and backgrounds of our team members. Marissa Korbel joined our team in late 2016. Marissa has been writing creatively and professionally since her college days. She was recently accepted into the prestigious and competitive Tin House Summer Workshop, which takes…

Read More

The End of the Road for HRSA’s 340B Mega Guidance?

A couple of weeks ago, we were in an uncertain landscape. On January 30, 2017, HRSA’s long-anticipated – and much debated — 340B “Mega Guidance” was withdrawn from the White House Office of Management and Budget (OMB). To move forward, the guidance would need to be resubmitted to OMB.

Read More

An Uncertain Landscape

Healthcare is an uncertain landscape at the moment. The incoming administration has promised a number of changes, including the potential repeal of the Affordable Care Act.  As a result, politicians, citizens, and companies don’t seem to have a handle on what is changing and what is staying the same. At CiiTA, we are also feeling…

Read More

CiiTA’s Changes

Among the perks of owning and growing a small business is that I get to celebrate the promotion of one of my colleagues, and also that I get to announce the hiring of two more.

Read More

A Win For Our Team

One of the prerogatives of being the leader of an extraordinary team of individuals is that you get to publicly recognize their success outside of the work hours as well.  Now is such an occasion. Gloria Harrison is a critical and valued member of the CiiTA team and is a close friend of us all.…

Read More

Introducing CiiTA LLC’s 340B Self-Reporting Assistance

Manufacturers are struggling with how best to respond to the increasing volume of 340B self-reporting offers and checks from Covered Entities.  In response, CiiTA is pleased to introduce the Manufacturer 340B Self-Reporting Assistance offering. CiiTA assists manufacturers by providing guidance and data analysis to support investigation into events triggering self-reporting letters and refund checks. Our…

Read More

Develop Your 340B Strategy

CiiTA has, through extensive experience, developed a set of best practices to help guide you through the creation of your 340B strategy. Download our process document to facilitate the development of your strategy.

Please enter your name.
Please enter a valid email address.
Something went wrong. Please check your entries and try again.